Penile blood pressure is useful to identify candidates for tadalafil treatment in patients with lower urinary tract symptoms.
Adrenergic alpha-1 Receptor Antagonists
/ therapeutic use
Aged
Aged, 80 and over
Blood Pressure
/ drug effects
Cholinergic Antagonists
/ therapeutic use
Humans
Male
Patient Selection
Penis
/ physiopathology
Phosphodiesterase 5 Inhibitors
/ therapeutic use
Prospective Studies
Prostatic Hyperplasia
/ complications
Prostatism
/ drug therapy
Severity of Illness Index
Tadalafil
/ therapeutic use
benign prostatic hyperplasia
lower urinary tract symptoms
penile blood pressure
phosphodiesterase inhibitors
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
20
6
2018
medline:
21
8
2019
entrez:
20
6
2018
Statut:
ppublish
Résumé
To determine whether penile blood pressure (PBP) can be used to identify patients who can benefit from tadalafil treatment, the correlation between PBP at baseline and changes in lower urinary tract symptoms (LUTS) induced by tadalafil treatment was studied prospectively. Patients with BPH who were poor responders to α In all, 51 patients were investigated. The IPSS in the low-PBP group decreased immediately after the start of treatment, and there was significant improvement in the IPSS from baseline at 4 and 12 weeks after the start of treatment, whilst the IPSS in the high-PBP group did not show significant changes. On multivariate analysis, PBP at baseline, anticholinergic drug use, and IPSS at baseline were significant predictors of a good IPSS response to tadalafil treatment. This study demonstrated that PBP could reliably identify patients with BPH who could benefit from tadalafil treatment. Patients with low PBP could be better responders to tadalafil.
Substances chimiques
Adrenergic alpha-1 Receptor Antagonists
0
Cholinergic Antagonists
0
Phosphodiesterase 5 Inhibitors
0
Tadalafil
742SXX0ICT
Types de publication
Journal Article
Langues
eng
Pagination
124-129Informations de copyright
© 2018 The Authors BJU International © 2018 BJU International Published by John Wiley & Sons Ltd.